Search Results - "Brooks, W. D. W."

Refine Results
  1. 1

    Tunable cavity optomechanics with ultracold atoms by Purdy, T P, Brooks, D W C, Botter, T, Brahms, N, Ma, Z-Y, Stamper-Kurn, D M

    Published in Physical review letters (24-09-2010)
    “…We present an atom-chip-based realization of quantum cavity optomechanics with cold atoms localized within a Fabry-Perot cavity. Effective subwavelength…”
    Get full text
    Journal Article
  2. 2

    5-lipoxygenase inhibitory activity of zileuton by Carter, G W, Young, P R, Albert, D H, Bouska, J, Dyer, R, Bell, R L, Summers, J B, Brooks, D W

    “…Zileuton [N-(1-benzo[b]thien-2-ylethyl)-N-hydroxyure] inhibited 5-hydroxyeicosatetraenoic acid synthesis by rat basophilic leukemia cell 20,000 x g supernatant…”
    Get more information
    Journal Article
  3. 3

    Optimization of the potency and duration of action of N-hydroxyurea 5-lipoxygenase inhibitors by Bell, R L, Bouska, J B, Malo, P E, Lanni, C, Harris, R R, Otis, E R, Stewart, A O, Brooks, D W, Carter, G W

    “…As in vitro glucuronidation assay and several biochemical assays were utilized to discover potent new N-hydroxyurea-containing 5-lipoxygenase inhibitors with…”
    Get more information
    Journal Article
  4. 4

    Nonsteroidal Anti-Inflammatory Drugs as Scaffolds for the Design of 5-Lipoxygenase Inhibitors by Kolasa, Teodozyj, Brooks, Clint D. W, Rodriques, Karen E, Summers, James B, Dellaria, Joseph F, Hulkower, Keren I, Bouska, Jennifer, Bell, Randy L, Carter, George W

    Published in Journal of medicinal chemistry (28-02-1997)
    “…Representative nonsteroidal anti-inflammatory drug (NSAID) cyclooxygenase inhibitors such as ibuprofen, naproxen, and indomethacin were used as orally…”
    Get full text
    Journal Article
  5. 5

    The discovery and development of zileuton: an orally active 5-lipoxygenase inhibitor by Bell, R L, Young, P R, Albert, D, Lanni, C, Summers, J B, Brooks, D W, Rubin, P, Carter, G W

    “…The enzyme 5-lipoxygenase is a key target in the effort to discover drugs which inhibit the pathophysiology associated with the formation of leukotrienes. The…”
    Get more information
    Journal Article
  6. 6
  7. 7
  8. 8

    Preclinical and clinical activity of zileuton and A-78773 by Bell, R L, Lanni, C, Malo, P E, Brooks, D W, Stewart, A O, Hansen, R, Rubin, P, Carter, G W

    Published in Annals of the New York Academy of Sciences (01-11-1993)
    “…The importance of leukotrienes as mediators of inflammation and bronchoconstriction was examined with two recently described 5-lipoxygenase inhibitors,…”
    Get more information
    Journal Article
  9. 9

    4-Hydroxythiazole inhibitors of 5-lipoxygenase by Kerdesky, Francis A. J, Holms, James H, Moore, Jimmie L, Bell, Randy L, Dyer, Richard D, Carter, George W, Brooks, Dee W

    Published in Journal of medicinal chemistry (01-07-1991)
    “…4-Hydroxythiazoles have been identified as potent inhibitors of 5-lipoxygenase in vitro exhibiting IC50's of less than 1 microM. An investigation of…”
    Get full text
    Journal Article
  10. 10

    Quantitative structure-activity relationships of 5-lipoxygenase inhibitors. Inhibitory potency of pyridazinone analogues by Kim, K H, Martin, Y C, Brooks, D W, Dyer, R D, Carter, G W

    Published in Journal of pharmaceutical sciences (01-03-1994)
    “…Quantitative structure-activity relationships (QSAR) of 72 1-phenyltetrahydropyridazin-3(2H)-one (I) analogues are examined for the inhibitory potency (IC50)…”
    Get more information
    Journal Article
  11. 11

    Clinical activity of leukotriene inhibitors by Harris, Richard R., Carter, George W., Bell, Randy L., Moore, Jimmie L., Brooks, Dee W.

    “…Data from the emerging clinical trials with compounds such as zileuton, ICI 204,219, Bay X1005, MK571, MK679, and MK591 are demonstrating the importance of the…”
    Get full text
    Journal Article Conference Proceeding
  12. 12

    Inhibition of leukotriene biosynthesis in the rat peritoneal cavity by Young, P R, Bell, R L, Lanni, C, Summers, J B, Brooks, D W, Carter, G W

    Published in European journal of pharmacology (03-12-1991)
    “…In the search for a model of leukotriene (LT) production to provide a method to determine in vivo 5-lipoxygenase (5-LO) inhibitory activity by various…”
    Get more information
    Journal Article
  13. 13
  14. 14

    5-Lipoxygenase Inhibitors:  Synthesis and Structure−Activity Relationships of a Series of 1-Aryl-2H,4H-tetrahydro-1,2,4-triazin-3-ones by Bhatia, Pramila A, Brooks, Clint D. W, Basha, Anwer, Ratajczyk, James D, Gunn, Bruce P, Bouska, Jennifer B, Lanni, Carmine, Young, Patrick R, Bell, Randy L, Carter, George W

    Published in Journal of medicinal chemistry (27-09-1996)
    “…Synthetic routes were developed to access a variety of novel 1-aryl-2H,4H-tetrahydro-1,2,4-triazin-3-one analogs which were evaluated as 5-lipoxygenase (5-LO)…”
    Get full text
    Journal Article
  15. 15
  16. 16
  17. 17
  18. 18

    The properties of A-69412: a small hydrophilic 5-lipoxygenase inhibitor by Bell, R L, Bouska, J, Young, P R, Lanni, C, Machinist, J, Malo, P E, Summers, J B, Brooks, D W, Carter, G W

    Published in Agents and Actions (01-03-1993)
    “…A compound which inhibits leukotriene biosynthesis could be clinically useful in treating several allergic and inflammatory diseases. One site for such…”
    Get full text
    Journal Article
  19. 19
  20. 20

    Time and Teaching by Zielinski, Theresa Julia, Brooks, David W, Crippen, Kent J, March, Joe L

    Published in Journal of chemical education (01-06-2001)
    “…Time management is an important issue for teachers and students. This article discusses teachers' use of time from the perspective of curriculum and…”
    Get full text
    Journal Article